Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 46.63M
March 31, 2026 43.50M
December 31, 2025 43.48M
September 30, 2025 42.66M
June 30, 2025 35.64M
March 31, 2025 35.23M
December 31, 2024 17.41M
September 30, 2024 16.28M
June 30, 2024 12.83M
March 31, 2024 12.34M
December 31, 2023 10.64M
September 30, 2023 10.29M
June 30, 2023 8.473M
March 31, 2023 8.330M
December 31, 2022 0.5538M
September 30, 2022 8.296M
June 30, 2022 7.486M
March 31, 2022 7.476M
December 31, 2021 7.476M
September 30, 2021 7.473M
June 30, 2021 7.470M
March 31, 2021 7.448M
December 31, 2020 6.975M
September 30, 2020 6.936M
June 30, 2020 6.702M
Date Value
March 31, 2020 6.486M
December 31, 2019 6.486M
September 30, 2019 6.483M
June 30, 2019 6.292M
March 31, 2019 5.036M
December 31, 2018 5.033M
September 30, 2018 5.026M
June 30, 2018 5.018M
March 31, 2018 4.003M
December 31, 2017 4.002M
September 30, 2017 4.000M
June 30, 2017 3.744M
March 31, 2017 3.739M
December 31, 2016 3.489M
September 30, 2016 3.485M
June 30, 2016 3.482M
March 31, 2016 3.474M
December 31, 2015 3.474M
September 30, 2015 3.467M
June 30, 2015 2.818M
March 31, 2015 2.874M
December 31, 2014 2.874M
September 30, 2014 2.398M
June 30, 2014 2.393M
March 31, 2014 2.389M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 78.87M
Neogen Corp. 217.70M
QuidelOrtho Corp. 68.30M
VolitionRX Ltd. 12.04M
Lucid Diagnostics, Inc. 190.76M